In April 2025, Vir Biotechnology Inc. announced a phase 1b/2 platform study framework to evaluate the safety and efficacy of ...

An in-depth look at Hepatitis D, why it’s so severe, and how new therapies bring hope for better treatment and prevention.

The following is a summary of “Chronic hepatitis B virus infection increases the risk of kidney disease while antiviral ...

Warminster-based Arbutus Biopharma laid off over half of its workforce and is leaving its headquarters to conserve cash while ...

Warminster-based Arbutus Biopharma laid off over half of its workforce and is exiting its headquarters to conserve cash while continuing its pursuit of ...

Catching HBV early can make a world of difference. Medical professionals typically use blood tests that check for signs of ...

Durham-based Precision BioSciences Inc. has received investigational new drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for PBGENE-HBV, an in vivo gene editing program designed ...

Xie Qing, director of infectious diseases department at Ruijin Hospital, which is affiliated with Shanghai Jiao Tong ...

Hepatitis B virus (HBV) infection is associated with liver diseases, including chronic hepatitis, which notably increases the risk of cirrhosis and hepatocellular carcinoma (HCC) development. Although ...

Gene editing is an advanced medical technique within gene therapy that involves precisely modifying an individual’s DNA to ...

While acute hepatitis B infection is often resolved by the immune system, CHB occurs when the body's defences are unable to ...

Aligos Therapeutics is a clinical-stage biotechnology company focused on improving patient outcomes through best-in-class ...